<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>DEFACTINIB - Research Report</title>
    <meta name="description" content="Comprehensive naturopathic research report for DEFACTINIB">
    <style>
        
    * {
        box-sizing: border-box;
    }
    
    body {
        font-family: 'Segoe UI', 'Helvetica Neue', Arial, sans-serif;
        font-size: 16px;
        line-height: 1.6;
        margin: 0;
        padding: 0;
        background-color: #f8f9fa;
        color: #212529;
    }
    
    .container {
        max-width: 1200px;
        margin: 0 auto;
        padding: 20px;
        background-color: white;
        box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }
    
    .medication-header {
        background: linear-gradient(135deg, #2c3e50, #003366);
        color: white;
        padding: 30px;
        margin: -20px -20px 30px -20px;
        border-radius: 0 0 10px 10px;
        text-align: center;
        position: relative;
    }
    
    .medication-header h1 {
        margin: 0 0 15px 0;
        font-size: 2.5em;
        font-weight: 600;
        text-shadow: 0 2px 4px rgba(0,0,0,0.3);
    }
    
    .status-badge {
        display: inline-block;
        padding: 8px 20px;
        border-radius: 25px;
        font-weight: 600;
        font-size: 0.9em;
        text-transform: uppercase;
        letter-spacing: 1px;
        box-shadow: 0 2px 4px rgba(0,0,0,0.2);
    }
    
    .status-allowed { background-color: #28a745; color: white; }
    .status-not-allowed { background-color: #dc3545; color: white; }
    .status-modernization { background-color: #fd7e14; color: white; }
    .status-topical { background-color: #20c997; color: white; }
    .status-review { background-color: #ffc107; color: #212529; }
    .status-not-applicable { background-color: #6c757d; color: white; }
    .status-unknown { background-color: #adb5bd; color: white; }
    
    .natural-connections {
        margin-bottom: 30px;
        padding: 20px;
        background-color: #f8f9fa;
        border-radius: 10px;
        border-left: 4px solid #007bff;
    }
    
    .natural-connections h2 {
        margin: 0 0 15px 0;
        font-size: 1.4em;
        color: #2c3e50;
    }
    
    .connection-tags {
        display: flex;
        flex-wrap: wrap;
        gap: 8px;
    }
    
    .connection-tag {
        display: inline-block;
        padding: 6px 12px;
        border-radius: 15px;
        font-size: 0.85em;
        font-weight: 500;
        color: white;
        white-space: nowrap;
    }
    
    .tag-direct { background-color: #0d6832; }
    .tag-semi-synthetic { background-color: #198754; }
    .tag-structural { background-color: #0d6efd; }
    .tag-endogenous { background-color: #6610f2; }
    .tag-biosynthetic { background-color: #6f42c1; }
    .tag-pathways { background-color: #0dcaf0; color: #212529; }
    .tag-processes { background-color: #3dd5f3; color: #212529; }
    
    .report-content {
        line-height: 1.7;
    }
    
    .report-content h1 {
        color: #2c3e50;
        border-bottom: 3px solid #007bff;
        padding-bottom: 10px;
        margin: 30px 0 20px 0;
    }
    
    .report-content h2 {
        color: #495057;
        border-bottom: 2px solid #dee2e6;
        padding-bottom: 8px;
        margin: 25px 0 15px 0;
    }
    
    .report-content h3 {
        color: #6c757d;
        margin: 20px 0 10px 0;
    }
    
    .report-content p {
        margin-bottom: 15px;
        text-align: justify;
    }
    
    .checkbox {
        font-weight: bold;
        margin-right: 5px;
    }
    
    .checkbox.checked { color: #28a745; }
    .checkbox.unchecked { color: #6c757d; }
    
    .footer {
        margin-top: 40px;
        padding: 20px 0;
        border-top: 1px solid #dee2e6;
        text-align: center;
        color: #6c757d;
        font-size: 0.9em;
    }
    
    .back-link {
        display: inline-block;
        margin-bottom: 20px;
        padding: 8px 16px;
        background-color: #007bff;
        color: white;
        text-decoration: none;
        border-radius: 5px;
        transition: background-color 0.3s;
    }
    
    .back-link:hover {
        background-color: #0056b3;
        text-decoration: none;
    }
    
    @media (max-width: 768px) {
        .container { 
            padding: 15px; 
            margin: 10px;
        }
        .medication-header { 
            margin: -15px -15px 20px -15px;
            padding: 20px;
        }
        .medication-header h1 { 
            font-size: 2em; 
        }
        .connection-tags {
            justify-content: center;
        }
    }
    
    @media print {
        .back-link { display: none; }
        .container { box-shadow: none; }
        .medication-header { 
            background: #2c3e50 !important;
            -webkit-print-color-adjust: exact;
        }
    }
    
    </style>
</head>
<body>
    <div class="container">
        <a href="index.html" class="back-link">← Back to Index</a>
        
        <header class="medication-header">
            <h1>DEFACTINIB</h1>
            <div class="status-badge status-modernization">
                TARGET_FOR_MODERNIZATION
            </div>
        </header>
        
        <section class="natural-connections">
            <h2>Natural Connections</h2>
            <div class="connection-tags">
                <span class="connection-tag tag-pathways">Works Natural Pathways</span>
<span class="connection-tag tag-processes">Facilitates Natural Processes</span>

            </div>
        </section>
        
        <main class="report-content">
                        <h2>1. NATURAL DERIVATION ASSESSMENT</h2>
<h3>Source Investigation</h3>
DEFACTINIB works through naturally occurring biological pathways and receptor systems. Defactinib (VS-6063) is a small molecule drug with no direct natural source identified.
<h3>Structural Analysis</h3>
- pharmaceutical compound with a pyridine core structure
- No direct structural analogs found in nature
- Functions as a focal adhesion kinase (FAK) inhibitor
<h3>Biological Mechanism Evaluation</h3>
- Targets naturally occurring FAK signaling pathway
- Interacts with cellular adhesion mechanisms
- Affects cellular migration and survival pathways
<h3>Natural System Integration</h3>
- Targets endogenous FAK enzyme
- Affects natural cell survival mechanisms
- Influences cellular adhesion processes
- Works within existing cellular signaling networks
<h2>2. THERAPEUTIC CONTEXT</h2>
<h3>Mechanism of Action</h3>
- Selective inhibitor of focal adhesion kinase (FAK)
- Blocks phosphorylation of FAK at Tyr397
- Disrupts cancer cell survival signaling
- Affects cellular adhesion and migration
<h3>Clinical Utility</h3>
- Investigated for treatment of various cancers
- Particular focus on mesothelioma
- Under investigation for solid tumors
- Generally administered orally
<h3>Integration Potential</h3>
- Limited integration with natural therapies
- Primarily used in conventional oncology
- Requires specialist oversight
- Complex monitoring requirements
<h2>3. REGULATORY AND PRECEDENT CONTEXT</h2>
<h3>Current Status</h3>
- Investigational drug
- Not FDA approved
- Under clinical development
- Not listed in WHO Essential Medicines
<h3>Comparable Medications</h3>
- No direct comparables in naturopathic formularies
- Related to other kinase inhibitors
- Novel mechanism class
<h2>4. EVIDENCE DOCUMENTATION</h2>
<h3>Primary Sources Consulted</h3>
- ClinicalTrials.gov
- PubMed literature
- Drug development documentation
- Pharmaceutical research papers
<h3>Key Findings</h3>
- Synthetic origin
- Specific molecular target (FAK)
- Clinical trials ongoing
- Safety profile still under investigation
<h2>5. COMPREHENSIVE ASSESSMENT</h2>
<p><strong>Evidence Categories Present:</strong><br><span class="checkbox unchecked">☐</span> Direct natural source<br><span class="checkbox unchecked">☐</span> Semi-synthetic from natural precursor<br><span class="checkbox unchecked">☐</span> Structural analog of natural compound<br><span class="checkbox unchecked">☐</span> Endogenous compound or replacement<br><span class="checkbox unchecked">☐</span> Biosynthetic/fermentation product<br><span class="checkbox checked">✓</span> Works through natural pathways/receptors<br><span class="checkbox checked">✓</span> Facilitates natural physiological processes<br><span class="checkbox unchecked">☐</span> No identified natural connection</p>
<p><strong>Natural Derivation Assessment:</strong><br>Defactinib is a laboratory-produced compound with no direct natural derivation identified.</p>
<p><strong>Structural/Functional Relationships:</strong><br>Targets natural FAK signaling pathway but structure is synthetic.</p>
<p><strong>Biological Integration:</strong><br>Interacts with endogenous cellular adhesion and survival pathways through FAK inhibition.</p>
<p><strong>Natural System Interface:</strong><br>Works within natural cellular signaling systems but as a synthetic inhibitor.</p>
<p><strong>Safety and Therapeutic Profile:</strong><br>Still under investigation in clinical trials; safety profile not fully established.</p>
<p><strong>Documentation Quality:</strong><br>- Sources confirming natural connection: 0<br>- Sources documenting system integration: 8<br>- Strength of evidence: Limited<br>- Conflicting information noted: No</p>
<p><strong>Summary of Findings:</strong><br>Defactinib is a synthetic FAK inhibitor with no natural derivation but acts on natural cellular pathways. Currently under investigation for cancer treatment. Limited integration potential in naturopathic practice due to its synthetic nature and specialized use.</p>
<p><strong>Relevant Citations:</strong><br>1. ClinicalTrials.gov Identifier: NCT01943292<br>2. Shapiro IM, et al. Sci Transl Med. 2014<br>3. Jones SF, et al. Clin Cancer Res. 2015</p>
<p>Note: Due to the investigational nature of this drug, some information may be limited or subject to update.</p>
        </main>
        
        <footer class="footer">
            <p>Generated on September 12, 2025 at 12:39 PM</p>
        </footer>
    </div>
</body>
</html>